ask="N/A"
ask_size="N/A"
average_daily_volume="489500"
bid="15.15"
bid_size="100"
book_value="6.19"
change="-1.00"
change_from_200_day_moving_average="0.24"
change_from_50_day_moving_average="-1.65"
change_from_52_week_high="-8.91"
change_From_52_week_low="16.42"
change_in_percent="-3.22%"
close="30.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="31.29"
high_52_weeks="38.92"
last_trade_date="1/23/2017"
last_trade_price="30.01"
last_trade_size="16925"
last_trade_time="4:00pm"
low="29.95"
low_52_weeks="13.59"
market_capitalization="1.56B"
moving_average_200_day="29.77"
moving_average_50_day="31.66"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="30.96"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.82%"
percent_change_from_50_day_moving_average="-5.21%"
percent_change_from_52_week_high="-22.89%"
percent_change_from_52_week_low="+120.82%"
previous_close="31.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.01"
price_per_sales="34.38"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="16.78"
stock_exchange="NGM"
symbol="TBPH"
volume="176269"
weeks_range_52="13.59 - 38.92"
